← back to search

Eric S. Christenson

Convergence · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Genetic factors in colorectal cancer, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, and Cancer Genomics and Diagnostics.
h-index
16
citations
1,236
works
126
NIH funding
—
primary concept
Medicine
email
echris14@jhmi.edu

Recent publications

Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
The Lancet Oncology 2020cited by 234position: firstdoi
Ki-67 is required for maintenance of cancer stem cells but not cell proliferation
Oncotarget 2016cited by 112position: middledoi
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity
Clinical Biochemistry 2014cited by 125position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ben Ho Park · Vanderbilt University Medical Center2 papers (2014–2016)Elizabeth M. Jaffee · NYU Langone Health1 papers (2020–2020)Nilofer S. Azad · Bloomberg (United States)1 papers (2020–2020)Morassa Mohseni · Johns Hopkins Medicine1 papers (2016–2016)Jessica Hicks · Johns Hopkins University1 papers (2016–2016)Ajay Chawla · University of California, San Francisco1 papers (2016–2016)Angelo M. De Marzo · Sidney Kimmel Cancer Center1 papers (2016–2016)— · 1 papers (2016–2016)Austin K. Mattox · Yale University1 papers (2016–2016)Sarah Croessmann · UPMC Hillman Cancer Center1 papers (2016–2016)Theodore James · Johns Hopkins Medicine1 papers (2014–2014)David Rosen · UNSW Sydney1 papers (2016–2016)David Chu · Johns Hopkins Medicine1 papers (2016–2016)Pedram Argani · Johns Hopkins University1 papers (2016–2016)Zeshaan A. Rasheed · Johns Hopkins Medicine1 papers (2016–2016)Julia A. Beaver · Aptose Biosciences (United States)1 papers (2016–2016)Daniel J. Zabransky · Convergence1 papers (2016–2016)Arielle J. Medford · Center for Cancer Research1 papers (2016–2016)Rory L. Cochran · Johns Hopkins Medicine1 papers (2016–2016)Josh Lauring · Johnson & Johnson (United States)1 papers (2016–2016)